Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Idiopathic Pulmonary Fibrosis: 5 Things to Know
C21 shows promise against COVID-19 where other drugs have failed
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Untangling the dualistic components of the RAS in PF the Yin and Yang